Preanalytic error tracking in a laboratory medicine department: results of a 1-year experience.

Anticancer Res 2003;23:3327–31. 4. Weikert S, Christoph F, Schrader M, Krause H, Miller K, Muller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 2005;116:100–4. 5. Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, Willems JL, Swinkels DW, et al. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 2004;50:1425–8. 6. Acar H, Kilinc M, Yildirim MS, Kaynak M, Cenker A. Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Cancer Genet Cytogenet 2003;142:25–9. 7. Vet JA, Hessels D, Marras SA, van de Kaa CA, van der Poel HG, Michalides RJ, et al. Comparative analysis of p53 mutations in bladder washings and histologic specimens. Am J Clin Pathol 1998;110:647–52. 8. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 C(T) method. Methods 2001;25:402–8.